Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
Clinical trial NCT03310190 · COMPLETED
Trial details
- NCT number
- NCT03310190
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-10
- Primary completion
- 2022-04-30
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.